Ann: PolyNovo presents at Macquarie Australia Conference, page-54

Omg. You go on and on about what you term “stagnating sales”
Prior to the CR late last year we hadn’t raised any cash for 5 full years!
And that was a meagre 25 mil.
Most developing biotechs raise that figure at least every 6 months on average. Look at MSB and AVH as examples. More so the former but the latter has also gone to the market multiple times for large sums of money in that 5 year period.
With that 25mil management has grown sales from circa 4 mil pa to circa 50, making very small annual losses along the way and preserving capital whilst growing the sales staff moderately aggressively and buying property, building and expanding the factory etc etc.
One quarter that isn’t stellar (but still contained a record month) and you jump on your soapbox and whinge and moan and lambast.
Give it a break - or at least give it til July and see what transpires.
Why do you think we are moving quickly into new jurisdictions? Our market share has increased 15 fold in the states in the last 5 years and it will naturally slow down a tad. Perfect timing to start concentrating more on other markets to maintain what to me is stellar growth of circa 50% pa.